Home > Healthcare > Vitamin D Therapy Market > Table of Contents

Vitamin D Therapy Market – Route of Administration (Oral, Parenteral), Type (OTC, Prescription), Application (Osteoporosis, Rickets, Muscle Weakness), Age Group (Children, Adults, Geriatric), Distribution Channel, Global Forecast (2024 – 2032)

  • Report ID: GMI9170
  • Published Date: Apr 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Growing awareness of vitamin D deficiency

3.2.1.2   Increasing ageing population

3.2.1.3   Availability of OTC drugs

3.2.2    Industry pitfalls & challenges

3.2.2.1   Side effects associated with therapy

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Porter's analysis

3.6    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Oral

5.3    Parenteral

Chapter 6   Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    OTC drugs

6.3    Prescription drugs

Chapter 7   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Osteoporosis

7.3    Muscle weakness

7.4    Rickets

7.5    Autoimmune disorders

7.6    Skin diseases

7.7    Other applications

Chapter 8   Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Geriatric

8.3    Adults

8.4    Children

Chapter 9   Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    Hospital pharmacies

9.3    Retail pharmacies

9.4    Online pharmacies

Chapter 10   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

10.1    Key trends

10.2    North America

10.2.1    U.S.

10.2.2    Canada

10.3    Europe

10.3.1    Germany

10.3.2    UK

10.3.3    France

10.3.4    Spain

10.3.5    Italy

10.3.6    Netherlands

10.3.7    Rest of Europe

10.4    Asia Pacific

10.4.1    China

10.4.2    Japan

10.4.3    India

10.4.4    Australia

10.4.5    South Korea

10.4.6    Rest of Asia Pacific

10.5    Latin America

10.5.1    Brazil

10.5.2    Mexico

10.5.3    Rest of Latin America

10.6    Middle East and Africa

10.6.1    South Africa

10.6.2    Saudi Arabia

10.6.3    UAE

10.6.4    Rest of Middle East and Africa

Chapter 11   Company Profiles

11.1    Abbott Laboratories

11.2    Alkem Laboratories Ltd.

11.3    Atrium Innovations

11.4    Biotics Research Corporation

11.5    Cadila Healthcare Ltd.

11.6    GlaxoSmithKline plc

11.7    Merck & Co. Inc.

11.8    Ortho Molecular Products

11.9    Pfizer, Inc.

11.10    Sanofi
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 329
  • Countries covered: 22
  • Pages: 187
 Download Free Sample